መነሻ › የጡንቻ ካንሰር › Texas › Fort Worth
በFort Worth፣ TX ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 11 ጥናቶች በFort Worth እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
IKS014 in Advanced Solid Tumors That Express HER2
ተሳታዮችን በመፈለግ ላይደረጃ 1
- START Dallas - Fort Worth, Fort Worth
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- JPS Health Network ( Site 0067), Fort Worth
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- JPS Oncology and Infusion Center ( Site 0083), Fort Worth
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- The Center for Cancer and Blood Disorders ( Site 0041), Fort Worth
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- JPS Health Network, Fort Worth
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- JPS Health Network - Trinity Springs Pavilion, Fort Worth
- OneR The Center For Cancer And Blood Disorders (Texas Cancer Care), Fort Worth
- UT Southwestern Moncrief Cancer Institute, Fort Worth
- እና 2 ተጨማሪ
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Start - Dfw, Fort Worth
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Research Site, Fort Worth
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- JPS Health Network, Fort Worth
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- USOR Texas Oncology, Fort Worth
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY134 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA111 ጥናቶች
- Nashville, TN80 ጥናቶች
- Los Angeles, CA72 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Durham, NC63 ጥናቶች
- Queens, NY63 ጥናቶች
- Chicago, IL58 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በFort Worth ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር18 ጥናቶች
- የእንቁላል ካንሰር17 ጥናቶች
- የኤንዶሜትሪየም ካንሰር12 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)9 ጥናቶች
- የፕሮስቴት ካንሰር9 ጥናቶች
- የልብ ድካም7 ጥናቶች
- የኮሎሬክታል ካንሰር7 ጥናቶች
- ትሪፕል-ኔጌቲቭ የደረት ካንሰር7 ጥናቶች
- Metastatic Cancer7 ጥናቶች
- የኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ)7 ጥናቶች
- አልሰራቲቭ ኮላይቲስ7 ጥናቶች
- ማኩላር ዴጀነሬሽን7 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።